MEETINGS - Second annual conference on the Surgical Treatment of Atrial Fibrillation (US) June 2002:
This article was originally published in Clinica
The second annual conference on the Surgical Treatment of Atrial Fibrillation will be held on June 19-20 2002 at the Sheraton New York Hotel and Towers, New York, US. The first day of the event aims to familiarise delegates with the latest devices with hands-on surgical procedure simulations. The scientific programme, on day two, is intended to demonstrate the latest developments in the surgical treatment of atrial fibrillation, focusing on surgical techniques and emerging technologies. The programme includes seven live-narrated demonstrations. For details tel: +1 714 799 1617; fax; +1 714 799 1686; email: email@example.com
You may also be interested in...
China’s Bio-Thera Solutions has received approval from the country’s NMPA to launch a Phase I clinical study comparing the pharmacokinetics and safety of its proposed ustekinumab biosimilar to Johnson & Johnson’s blockbuster psoriasis drug Stelara, the latest in a string of the biotech company’s products to advance into clinical development.
A regulatory framework that encourages physicians to conduct experimental cell and gene therapies have propelled China to become a major developer of such promising cancer-treating tools, but insiders say three are a plethora issues at stake.